Efficacy of direct oral anticoagulants on left ventricular thrombusTurgay Yildirim, Özgea; Akşit, Ercanb; Aydin, Fatiha; Hüseyinoğlu Aydin, AyşeaBlood Coagulation & Fibrinolysis: April 2019 - Volume 30 - Issue 3 - p 96–103 doi: 10.1097/MBC.0000000000000801 REVIEW ARTICLES Buy Abstract Author InformationAuthors Article MetricsMetrics Left ventricular thrombus (LVT) is a commonly seen complication of myocardial infarction and it also can be seen because of hypertrophic cardiomyopathies, nonischemic dilated cardiomyopathies, malignancies, and so on. Guidelines suggest the use of warfarin for left ventricular thrombi, but recent case reports show that direct oral anticoagulants (DOACs) are beginning to be used for this complication. DOACs are strong alternatives for warfarin because of their efficacy and safety even though there is no randomized controlled trial that proves the effect of DOACs against LVT. In this article, we gather the case reports of DOACs against left ventricular thrombi in various conditions. aDepartment of Cardiology, Eskisehir State Hospital, Eskisehir bDepartment of Cardiology, Canakkale Onsekiz Mart University, Çanakkale, Turkey Correspondence to Özge Turgay Yildirim, MD, Çamlica Mah, Güfte Sokak Natura Evleri A1 Blok Daire 3Tepebaşi/Eskişehir Tel: +905326876626; e-mail: firstname.lastname@example.org Received 17 October, 2018 Revised 21 January, 2019 Accepted 19 February, 2019 Copyright © 2019 YEAR Wolters Kluwer Health, Inc. All rights reserved.